Podcast: Why Hyderabad's Biological E could be the dark horse in India's vaccine race

Forbes India's Manu Balachandran and Divya Shekhar take a jab at why this southern company, which may be a few laps behind the bigwigs in vaccine trials, could make up for lost time in its ability to scale. Will it play a big role in vaccinating India? Find out on this episode